Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood mineral levels may differ in women's reproductive diseases

NCT ID NCT07210918

Knowledge-focused Sponsor: Cumhuriyet University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study measured 14 trace elements in blood samples from 40 women with endometriosis, ovarian cancer, endometrial cancer, or healthy controls. Researchers wanted to see if levels of elements like iron, selenium, or lead differ between these groups. The goal is to find clues that could help with diagnosis or understanding of these conditions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If patterns are found, this could point toward new ways to screen for or understand these gynecological conditions.
What could go wrong
This is a small, completed observational study with only 40 participants. Results may not apply to larger populations and do not test any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

40 people

The number who actually took part.

Started

Apr 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Not having received chemotherapy, radiotherapy or immunotherapy in the last three months * For the endometriosis group: histopathologically or laparoscopically confirmed endometriosis * For the ovarian cancer group: histopathologically confirmed epithelial ovarian cancer * For the endometrial cancer group: histopathologically confirmed endometrial adenocarcinoma * For the control group: healthy individuals who underwent surgery for benign gynecological causes (e.g., myoma, benign cyst) and who were not diagnosed with malignancy/endometriosis Exclusion Criteria: * Chronic systemic diseases (e.g., chronic renal failure, liver disease, severe cardiac disease) * Diseases that may affect metabolism or trace element levels (e.g., Wilson's disease, hemochromatosis) * Use of dietary supplements containing minerals or trace elements within the past 6 months * Environmental or occupational heavy metal exposure (e.g., mining, metallurgy, battery industry workers) * Pregnancy or breastfeeding * History of acute infection or inflammatory disease * History of recurrent surgery or advanced metastatic cancer (as this may alter serum parameters) * Psychiatric or cognitive disorders that preclude participation in the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Endometrial adenocarcinoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer endometrial cancer endometriosis endometrium adenocarcinoma endometrium neoplasm ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Endometrial cancer Endometriosis Healthy control Over cancer

Contacts and locations

Locations

  • sivas Cumhuriyet University

    Sivas, Centre, 58146, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.